Responses
Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
616 A novel non-covalent linker peptide with nanomolar affinity for clinical IgG1 antibodies preserves antibody-antigen affinity and drug potency against PDL1+ melanoma when conjugated with DM1
Compose a Response to This Article
Other responses
No responses have been published for this article.
